Most infection prevention guidelines center on the hospital environment rather than the patient. But the source of antibiotic-resistant microbes is often from the patient’s own body.
Articles on Multidrug-resistant microbes
Displaying all articles
Researchers uncovered the foundations of biology by using E. coli as a model organism. But over-reliance on this microbe can lead to knowledge blind spots with implications for antibiotic resistance.
Multidrug-resistant fungal infections are an emerging global health threat. Figuring out how fungi evade treatments offers new avenues to counter resistance.
The US currently has only one antibiotic available to treat gonorrhea – and it’s becoming less effective.
If no action is taken to address antibiotic resistance, infections from multidrug-resistant bacteria could cause 10 million deaths each year by 2050.
Antibiotic resistance is one of the biggest public health threats in the world. New research, however, may have found a way to keep up with rapidly evolving bacteria.
Prevention may be the best way to cope with the worldwide wave of treatment-resistant fungal pathogens.
Top contributors
-
Associate Professor of Microbiology, Cornell University
-
Professor of Biochemistry and Molecular Biology, Penn State
-
Associate Professor of Allergy and Infectious Diseases, School of Medicine, University of Washington
-
Ph.D. Candidate in Microbiology, Cornell University
-
Dean of the College of Science, Professor of Biochemistry, Rochester Institute of Technology
-
PhD Candidate in Chemical Engineering, University of Colorado Boulder
-
Assistant Professor of Anesthesiology, School of Medicine, University of Washington
-
Regents' Professor & Chair, Medical Laboratory Science, Texas State University
-
Professor of Biological Sciences, University of Maryland, Baltimore County